Gresham House Strategic takes private equity public

Gresham House Strategic makes its returns from applying private equity techniques to listed companies. But its strategy could also prove profitable for more traditional GPs.

NorthEdge eyes a sugar-free success story

The firm’s investment in soft beverages company Clearly Drinks looks set to benefit from the upcoming sugar tax.

Abac hopes to get Spain in shape with PronoKal acquisition

PronoKal now has sales in excess of €42m and presence in 15 countries in Europe and Latin America, with a patient base of over 300,000 people and more than 2,500 prescribing doctors.
impact investment

Going mainstream: how private equity firms can approach impact investment

Real Deals attended the Impact Investing World Forum last month to gauge the latest trends from this burgeoning sector.

Graphite Capital overcomes bumps in the road for 3.7x Micheldever exit

The firm navigated a challenging recession period and sold the tyre business to Japanese trade buyer Sumitomo for £215m this month.

Regional review 2016: Uncertainty rules in the UK

Brexit loomed large over the private equity industry in 2016. It will continue to do so in 2017 and beyond.

Regional review 2016: The song remains the same in DACH

Are Germany's gates finally opening to foreign investors?

The top private equity stories of 2016

In a year dominated by geopolitical upheaval, private equity witnessed its own turbulence in 2016 with hostile takeovers, empire building and the mega-exit of one very interesting portfolio company.

Fundraising in 2016: From strength to strength

After another bumper year private equity fundraising is showing no sign of slowing down.

Secondaries in 2016: the freight train rolls on

Even though deal value softened in 2016, secondaries investors enjoyed another strong year thanks to record war chests and narrow discounts.
- Advertisement -